Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
This report researches the worldwide Antimicrobial Growth Promoters market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Antimicrobial Growth Promoters breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Antimicrobial growth promoters (AGPs) are antibiotics added to the feed of food animals to enhance their growth rate and production performance. The mechanism by which AGPs work is not clear. AGPs reduce normal intestinal flora (which compete with the host for nutrients) and harmful gut bacteria (which may reduce performance by causing subclinical disease). The effect on growth may be due to a combination of both fewer normal intestinal flora and fewer harmful bacteria
There has been a developing controversy surrounding the use of antibiotics as growth promoters for food animals. These drugs are used at low doses in animal feeds and are considered to improve the quality of the product, with a lower percentage of fat and a higher protein content in the meat. Other benefits of the use of antibiotic growth-promoters include control of zoonotic pathogens such as Salmonella, Campylobacter, Escherichia coli and enterococci. Use of any antibiotic is associated with the selection of resistance in pathogenic bacteria and it has been argued that the use of antibiotic growth-promoters imposes a selection pressure for bacteria that are resistant to antibiotics that may be used in clinical or veterinary practice, thus compromising the continued use of antimicrobial chemotherapy.
Global Antimicrobial Growth Promoters market size will increase to xx Million US$ by 2025, from xx Million US$ in 2017, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Antimicrobial Growth Promoters.
This report focuses on the top manufacturers' Antimicrobial Growth Promoters capacity, production, value, price and market share of Antimicrobial Growth Promoters in global market. The following manufacturers are covered in this report:
Cargill
Royal DSM
Zoetis
Alltech
Elanco Animal Health
Merck Animal Health
Bayer Animal Health
Biomin Holding
Boehringer Ingelheim
Bupo Animal Health
Danisco
Novus International
Vetoquinol
Antimicrobial Growth Promoters Breakdown Data by Type
Penicillins
Incosamides
Macrolides
Others
Antimicrobial Growth Promoters Breakdown Data by Application
Animal Feed
Therapeutic Antimicrobial Drugs
Other
Antimicrobial Growth Promoters Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Antimicrobial Growth Promoters Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Antimicrobial Growth Promoters capacity, production, value, consumption, status and forecast;
To focus on the key Antimicrobial Growth Promoters manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Antimicrobial Growth Promoters :
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
This study categorizes the global Antimicrobial Growth Promoters breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Antimicrobial growth promoters (AGPs) are antibiotics added to the feed of food animals to enhance their growth rate and production performance. The mechanism by which AGPs work is not clear. AGPs reduce normal intestinal flora (which compete with the host for nutrients) and harmful gut bacteria (which may reduce performance by causing subclinical disease). The effect on growth may be due to a combination of both fewer normal intestinal flora and fewer harmful bacteria
There has been a developing controversy surrounding the use of antibiotics as growth promoters for food animals. These drugs are used at low doses in animal feeds and are considered to improve the quality of the product, with a lower percentage of fat and a higher protein content in the meat. Other benefits of the use of antibiotic growth-promoters include control of zoonotic pathogens such as Salmonella, Campylobacter, Escherichia coli and enterococci. Use of any antibiotic is associated with the selection of resistance in pathogenic bacteria and it has been argued that the use of antibiotic growth-promoters imposes a selection pressure for bacteria that are resistant to antibiotics that may be used in clinical or veterinary practice, thus compromising the continued use of antimicrobial chemotherapy.
Global Antimicrobial Growth Promoters market size will increase to xx Million US$ by 2025, from xx Million US$ in 2017, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Antimicrobial Growth Promoters.
This report focuses on the top manufacturers' Antimicrobial Growth Promoters capacity, production, value, price and market share of Antimicrobial Growth Promoters in global market. The following manufacturers are covered in this report:
Cargill
Royal DSM
Zoetis
Alltech
Elanco Animal Health
Merck Animal Health
Bayer Animal Health
Biomin Holding
Boehringer Ingelheim
Bupo Animal Health
Danisco
Novus International
Vetoquinol
Antimicrobial Growth Promoters Breakdown Data by Type
Penicillins
Incosamides
Macrolides
Others
Antimicrobial Growth Promoters Breakdown Data by Application
Animal Feed
Therapeutic Antimicrobial Drugs
Other
Antimicrobial Growth Promoters Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Antimicrobial Growth Promoters Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Antimicrobial Growth Promoters capacity, production, value, consumption, status and forecast;
To focus on the key Antimicrobial Growth Promoters manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Antimicrobial Growth Promoters :
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
